Trials / Completed
CompletedNCT06795165
Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation
A Single-center, Investigator-masked, Randomized, Placebo-controlled, Investigator-initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Eye Research Foundation, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxidectin 2 MG Oral Tablet | active medication |
| DRUG | Placebo | placebo pills |
Timeline
- Start date
- 2025-02-02
- Primary completion
- 2025-04-28
- Completion
- 2025-06-15
- First posted
- 2025-01-27
- Last updated
- 2025-08-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06795165. Inclusion in this directory is not an endorsement.